Daniela Thommen

Daniela Thommen is a Junior Group Leader at the Netherlands Cancer Institute. She received her MD and PhD from the University of Basel, Switzerland. She then specialized in Medical Oncology in Switzerland. In parallel to her clinical training, she worked as a research fellow in tumor immunology in the lab of Prof. Alfred Zippelius at the Department of Biomedicine in Basel. In 2016, she joined the lab of Prof. Ton Schumacher at the Netherlands Cancer Institute in Amsterdam as a postdoctoral fellow. In 2020, she started her own lab there. Her research focuses on understanding the role of intratumoral immune cell heterogeneity for immunotherapy response and on the development of novel biomarkers and personalized immunotherapy strategies using patient-derived organotypic models. Daniela Thommen is the recipient of a 2018 Bas Mulder Award from the Dutch Cancer Society, of the 2019 Swiss Pfizer Research Prize in Oncology and of a 2022 NWO Vidi award.